Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “PHASE STUDIES”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 361 records · Page 20

Systematic Phase Curve Study of Known Transiting Systems from Year One of the TESS Mission

We present a systematic phase curve analysis of known transiting systems observed by the Transiting Exoplanet Survey Satellite (TESS) during year one of the primary mission. Using theoretical predictions for the amplitude of the planetary longitudinal atmospheric brightness modulation, stellar ellipsoidal distortion and Doppler boosting, as well as brightness considerations to select targets with likely detectable signals, we applied a uniform data processing and light-curve modeling framework to fit the full-orbit phase curves of 22 transiting systems with planet-mass or brown dwarf companions, including previously published systems. Statistically significant secondary eclipse depths and/or atmospheric brightness modulation amplitudes were measured for HIP 65A, WASP-18, WASP-19, WASP-72, WASP-100, WASP-111, WASP-121, and WASP-122/KELT-14. For WASP-100b, we found marginal evidence that the brightest region of the atmosphere is shifted eastward away from the substellar point. We detected significant ellipsoidal distortion signals in the light curves of HIP 65A, TOI-503, WASP-18, and WASP-30, with HIP 65A, TOI-503 and WASP-18 also exhibiting Doppler boosting. The measured amplitudes of these signals agree with the predictions of theoretical models. Combining the optical secondary eclipse depths with previously published Spitzer 3.6 and 4.5 μm measurements, we derived dayside brightness temperatures and visible-light geometric albedos for a subset of the analyzed systems. We also calculated updated transit ephemerides combining the transit timings from the TESS light curves with previous literature values.

Ian Wong↗

In-situ high-energy x-ray diffuse-scattering study of the phase transition of Ni{sub 2}MnGa single crystal under high magnetic field.

The defects-related microstructural features connected to the premartensitic and martensitic transition of a Ni{sub 2}MnGa single crystal under a high magnetic field of 50 KOe applied along the [1{bar 1}0] crystallographic direction of the Heusler phase were studied by the in-situ high-energy X-ray diffuse-scattering experiments on the high energy synchrotron beam line 11-ID-C of APS and thermomagnetization measurements. Our experiments show that a magnetic field of 50 KOe applied along the [1{bar 1}0] direction of the parent Heusler phase can promote the premartensitic transition of Ni{sub 2}MnGa single crystal, but puts off martensite transition and the reverse transition. The premartensitic transition temperature (T{sub PM}) increases from 233 to 250 K (-40 to -23 C). The martensite transition start temperature (M{sub s}) decreases from 175 to 172 K (-98 to -101 C), while the reverse transition start temperature (A{sub s}) increases from 186 to 189 K (-87 to -84 C). The high magnetic field leads to a rapid rearrangement of martensite variants below the martensite transition finish temperature (M{sub f}). The real transition process of Ni{sub 2}MnGa single crystal under the high magnetic field was in-situ traced.

43 PARTICLE ACCELERATORS↗

The pressure-induced phase transition studies of In{sub 2}S{sub 3} and In{sub 2}S{sub 3}:Ce nanoparticles

A novel method, gas–liquid phase chemical deposition is developed to prepare In{sub 2}S{sub 3} and In{sub 2}S{sub 3}:Ce nanoparticles. The structural, morphology and composition feature of these two nanoparticles is studied by XRD, HRTEM, and XPS. In situ high-pressure synchrotron X-ray diffraction studies were carried out by using a diamond-anvil cell. The doping does not influence the tetragonal-to-cubic phase transition path while results in a lower phase transition pressure of In{sub 2}S{sub 3}:Ce nanoparticles (4.3 GPa) than that of In{sub 2}S{sub 3} nanoparticles (7.1 GPa). The bulk moduli of tetragonal phases are B{sub 0}=87.1±4.3 GPa and B{sub 0}=55.6±4.1 GPa, respectively. The distinct high-pressure behaviors can be explained in term of the doped ions, causing lattice distortion and reducing structural stability of the In{sub 2}S{sub 3} nanoparticles and further accelerating the phase transition. - Graphical abstract: The phase transition of the In{sub 2}S{sub 3} and In{sub 2}S{sub 3}:Ce nanoparticles have been investigated for the first time by in situ high pressure synchrotron X-ray in a diamond anvil cell. Display Omitted - Highlights: • The high-pressure behaviors of In{sub 2}S{sub 3} and In{sub 2}S{sub 3}:Ce have been investigated. • The pressure-induced tetragonal-to-cubic phase transitions have been observed. • The phase transition pressure of In{sub 2}S{sub 3}:Ce is lower than that of In{sub 2}S{sub 3} nanoparticles. • The distinct high-pressure behaviors are ascribed to the dopants. • The doping causes lattice distortion reducing the structural stability.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗

Phased-Array Study of Dual-Flow Jet Noise: Effect of Nozzles and Mixers

A 16-microphone linear phased-array installed parallel to the jet axis and a 32-microphone azimuthal phased-array installed in the nozzle exit plane have been applied to identify the noise source distributions of nozzle exhaust systems with various internal mixers (lobed and axisymmetric) and nozzles (three different lengths). Measurements of velocity were also obtained using cross-stream stereo particle image velocimetry (PIV). Among the three nozzle lengths tested, the medium length nozzle was the quietest for all mixers at high frequency on the highest speed flow condition. Large differences in source strength distributions between nozzles and mixers occurred at or near the nozzle exit for this flow condition. The beamforming analyses from the azimuthal array for the 12-lobed mixer on the highest flow condition showed that the core flow and the lobe area were strong noise sources for the long and short nozzles. The 12 noisy spots associated with the lobe locations of the 12-lobed mixer with the long nozzle were very well detected for the frequencies 5 KHz and higher. Meanwhile, maps of the source strength of the axisymmetric splitter show that the outer shear layer was the most important noise source at most flow conditions. In general, there was a good correlation between the high turbulence regions from the PIV tests and the high noise source regions from the phased-array measurements.

Soo Lee, Sang↗

Study of cerium phase transitions in shock wave experiments

Cerium has a complex phase diagram that is explained by the presence of structural phase transitions. Experiments to measure the sound velocities in cerium by two methods were carried out to determine the onset of cerium melting on the Hugoniot. In the pressure range 4-37 GPa, the sound velocity in cerium samples was measured by the counter release method using manganin-based piezoresistive gauges. In the pressure range 35-140 GPa, the sound velocity in cerium was measured by the overtaking release method using carbogal and tetrachloromethane indicator liquids. The samples were loaded with plane shock wave generators using powerful explosive charges. The onset of cerium melting on the Hugoniot at a pressure of about 13 GPa has been ascertained from the measured elastic longitudinal and bulk sound velocities.

75 CONDENSED MATTER PHYSICS, SUPERCONDUCTIVITY AND↗

Beryllium fastener technology

Program was conducted to develop, produce, and test optimum-configuration, beryllium prestressed and blind fasteners. The program was carried out in four phases - phase 1, feasibility study, phase 2, development, phase 3, evaluation of beryllium alloys, and phase 4, fabrication and testing.

Glackin, J. J.↗

Phase 1 Study of Erlotinib Plus Radiation Therapy in Patients With Advanced Cutaneous Squamous Cell Carcinoma

Purpose: To assess the toxicity profile of erlotinib therapy combined with postoperative adjuvant radiation therapy in patients with advanced cutaneous squamous cell carcinoma. Methods and Materials: This was a single-arm, prospective, phase 1 open-label study of erlotinib with radiation therapy to treat 15 patients with advanced cutaneous head-and-neck squamous cell carcinoma. Toxicity data were summarized, and survival was analyzed with the Kaplan-Meier method. Results: The majority of patients were male (87%) and presented with T4 disease (93%). The most common toxicity attributed to erlotinib was a grade 2-3 dermatologic reaction occurring in 100% of the patients, followed by mucositis (87%). Diarrhea occurred in 20% of the patients. The 2-year recurrence rate was 26.7%, and mean time to cancer recurrence was 10.5 months. Two-year overall survival was 65%, and disease-free survival was 60%. Conclusions: Erlotinib and radiation therapy had an acceptable toxicity profile in patients with advanced cutaneous squamous cell carcinoma. The disease-free survival in this cohort was comparable to that in historical controls.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Spacelab data management subsystem phase B study

The Spacelab data management system is described. The data management subsystem (DMS) integrates the avionics equipment into an operational system by providing the computations, logic, signal flow, and interfaces needed to effectively command, control, monitor, and check out the experiment and subsystem hardware. Also, the DMS collects/retrieves experiment data and other information by recording and by command of the data relay link to ground. The major elements of the DMS are the computer subsystem, data acquisition and distribution subsystem, controls and display subsystem, onboard checkout subsystem, and software. The results of the DMS portion of the Spacelab Phase B Concept Definition Study are analyzed.

Source record↗

Dose-finding studies in drug development for rare genetic diseases

The small patient populations inherent to rare genetic diseases present many challenges to the traditional drug development paradigm. One major challenge is generating sufficient data in early phase studies to inform dose selection for later phase studies and dose optimization for clinical use of the drug. However, optimizing the benefit-risk profile of drugs through appropriate dose selection during drug development is critical for all drugs, including those being developed to treat rare diseases. Recognizing the challenges of conducting dose finding studies in rare disease populations and the importance of dose selection and optimization for successful drug development, we assessed the dose-finding studies and analyses conducted for drugs recently approved for rare genetic diseases. Of the 40 marketing applications for new molecular entity (NME) drugs and biologics approved by the United States Food and Drug Administration for rare genetic diseases from 2015 to 2020, 21 (53%) of the development programs conducted at least one dedicated dose-finding study. In addition, the majority of drug development programs conducted clinical studies in healthy subjects and included population pharmacokinetic and exposure–response analyses; some programs also conducted clinical studies in patient populations other than the disease for which the drug was initially approved. The majority of primary endpoints utilized in dedicated dose-finding studies were biomarkers, and the primary endpoint of the safety and efficacy study matched the primary endpoint used in the dose finding study in 9 of 13 (69%) drug development programs where primary study endpoints were assessed. Our study showed that NME drug development programs for rare genetic diseases utilize multiple data sources for dosing information, including studies in healthy subjects, population pharmacokinetic analyses, and exposure–response analyses. In addition, our results indicate that biomarkers play a key role in dose-finding studies for rare genetic disease drug development programs. Our findings highlight the need to develop study designs and methods to allow adequate dose-finding efforts within rare disease drug development programs that help overcome the challenges presented by low patient prevalence and other factors. Furthermore, the frequent reliance on biomarkers as endpoints for dose-finding studies underscores the importance of biomarker development in rare diseases.

60 APPLIED LIFE SCIENCES↗

In-situ synchrotron x-ray study of phase transitions in melamine under high pressures and high temperatures

We report a synchrotron energy-dispersive x-ray diffraction study of melamine at high pressure and high temperature. Pressure was generated using a Paris-Edinburgh cell to employ larger sample volumes for weakly scattering organic samples. High temperatures were created using a resistive/graphitic cup surrounding the sample. The PT phase diagram was explored by first pressurizing the sample to 3.5 GPa at room temperature and then heating it up to 1197 K with a concomitant pressure increase to just above 5 GPa. Above 4.85 GPa and 967 K, an irreversible phase transition was observed. Upon cooling the sample, another phase transition was observed which is likely associated with polymerization observed in earlier ex-situ HPHT experiments.

36 MATERIALS SCIENCE↗

Measurement bias in self-heating x-ray free electron laser experiments from diffraction studies of phase transformation in titanium

X-ray self-heating is a common by-product of X-ray Free Electron Laser (XFEL) techniques that can affect targets, optics, and other irradiated materials. Diagnosis of heating and induced changes in samples may be performed using the x-ray beam itself as a probe. However, the relationship between conditions created by and inferred from x-ray irradiation is unclear and may be highly dependent on the material system under consideration. Here, we report on a simple case study of a titanium foil irradiated, heated, and probed by a MHz XFEL pulse train at 18.1 keV delivered by the European XFEL using measured x-ray diffraction to determine temperature and finite element analysis to interpret the experimental data. We find a complex relationship between apparent temperatures and sample temperature distributions that must be accounted for to adequately interpret the data, including beam averaging effects, multivalued temperatures due to sample phase transitions, and jumps and gaps in the observable temperature near phase transformations. The results have implications for studies employing x-ray probing of systems with large temperature gradients, particularly where these gradients are produced by the beam itself. Finally, this study shows the potential complexity of studying nonlinear sample behavior, such as phase transformations, where biasing effects of temperature gradients can become paramount, precluding clear observation of true transformation conditions.

Crystallography↗

Orbital-Phase-Resolved Study of OAO 1657-415 in Spin-Up and Spin-Down

We observed the 38-s X-ray pulsar OAO 1657-415 in a series of daily snapshots spanning its 10-day binary orbit, on three different occasions corresponding to different accretion torque states. The goal was to see if the previously observed drastic variability in X-ray spectral properties showed a systematic pattern with respect to orbital phase or torque state. Our study failed to identify any systematic patterns, although considerably stochastic variability was observed. Overall, our results were inconclusive. We chose not to prepare a journal paper on this study, although the data were shared with several other groups interested in monitoring the properties of this source.

Chakrabarty, Deepto↗

NIAC Phase I Study Final Report on Large Ultra-Lightweight Photonic Muscle Space Structures

The research goal is to develop new tools support NASA's mission of understanding of the Cosmos by developing cost effective solutions that yield a leap in performance and science data. 'Maikalani' in Hawaiian translates to, "knowledge we gain from the cosmos." Missions like Hubble have fundamentally changed humanity's view of the cosmos. Last year's Nobel prize in physics was a result of astronomical discoveries. $9B class JWST size (6.5 meter diameter) space telescopes, when launched are anticipated to rewrite our knowledge of physics. Here we report on a neoteric meta-material telescope mirror technology designed to enable a factor of 100 or more reduction in areal density, a factor of 100 reduction in telescope production and launch costs as well as other advantages; a leap to enable missions to image the cosmos in unprecedented detail, with the associated gain in knowledge. Whether terahertz, visible or X-ray, reflectors used for high quality electromagnetic imaging require shape accuracy (surface figure) to far better than 1 wavelength (lambda) of the incident photons, more typically lambda/10 or better. Imaging visible light therefore requires mirror surfaces that approximate a desired curve (e.g. a sphere or paraboloid) with smooth shape deviation of th less than approximately 1/1000 the diameter of a human hair. This requires either thick high modulus material like glass or metal, or actuators to control mirror shape. During Phase I our team studied a novel solution to this systems level design mass/shape tradespace requirement both to advance the innovative space technology concept and also to help NASA and other agencies meet current operational and future mission requirements. Extreme and revolutionary NASA imaging missions such as Terrestrial Planet Imager (TPI) require lightweight mirrors with minimum diameters of 20 to 40 meters. For reference, NASA's great achievement; the Hubble space telescope, is only 2.4 meters in diameter. What is required is a way to make large inexpensive deployable mirrors where the cost is measured in millions, not billions like current efforts. For example we seek an interim goal within 10 years of a Hubble size (2.4m) primary mirror weighing 1 pound at a cost of 10K in materials. Described here is a technology using thin ultra lightweight materials where shape can be controlled simply with a beam of light, allowing imaging with incredibly low mass yet precisely shaped mirrors. These " Photonic Muscle" substrates will eventually make precision control of giant s p a c e apertures (mirrors) possible. OCCAM substrates make precision control of giant ultra light-weight mirror apertures possible. This technology is posed to create a revolution in remote sensing by making large ultra lightweight space telescopes a fiscal and material reality over the next decade.

Cosmos↗

Experimental Phase Equilibria Studies of the Pb-Fe-O System in Air, in Equilibrium with Metallic Lead and at Intermediate Oxygen Potentials

The phase equilibria information on the Pb-Fe-O system is of practical importance for the improvement of the existing thermodynamic database of lead-containing slag systems (Pb-Zn-Fe-Cu-Si-Ca-Al-Mg-O). Phase equilibria of the Pb-Fe-O system have been investigated: (a) in air at temperatures between 1053 K and 1373 K (780 °C and 1100 °C); (b) in equilibrium with metallic lead at temperatures between 1053 K and 1373 K (780 °C and 1100 °C); and (c) at intermediate oxidation conditions for the liquid slag in equilibrium with two solids (spinel + magnetoplumbite), at temperatures between 1093 K and 1373 K (820 °C and 1100 °C). The high-temperature equilibration/quenching/electron probe X-ray microanalysis technique has been used to accurately determine the compositions of the phases in equilibrium in the system. The Pb and Fe concentrations in the phases were determined directly; preliminary thermodynamic modeling with FactSage was used to estimate the ferrous-to-ferric ratios and to present the results in the ternary diagram.

36 MATERIALS SCIENCE↗

Efficacy Endpoints of Radiation Therapy Group Protocol 0247: A Randomized, Phase 2 Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer

Purpose: To report secondary efficacy endpoints of Radiation Therapy Oncology Group protocol 0247, primary endpoint analysis of which demonstrated that preoperative radiation therapy (RT) with capecitabine plus oxaliplatin achieved a pathologic complete remission prespecified threshold (21%) to merit further study, whereas RT with capecitabine plus irinotecan did not (10%). Methods and Materials: A randomized, phase 2 trial evaluated preoperative RT (50.4 Gy in 1.8-Gy fractions) with 2 concurrent chemotherapy regimens: (1) capecitabine (1200 mg/m{sup 2}/d Monday-Friday) plus irinotecan (50 mg/m{sup 2}/wk × 4); and (2) capecitabine (1650 mg/m{sup 2}/d Monday-Friday) plus oxaliplatin (50 mg/m{sup 2}/wk × 5) for clinical T3 or T4 rectal cancer. Surgery was performed 4 to 8 weeks after chemoradiation, then 4 to 6 weeks later, adjuvant chemotherapy (oxaliplatin 85 mg/m{sup 2}; leucovorin 400 mg/m{sup 2}; 5-fluorouracil 400 mg/m{sup 2}; 5-fluorouracil 2400 mg/m{sup 2}) every 2 weeks × 9. Disease-free survival (DFS) and overall survival (OS) were estimated univariately by the Kaplan-Meier method. Local–regional failure (LRF), distant failure (DF), and second primary failure (SP) were estimated by the cumulative incidence method. No statistical comparisons were made between arms because each was evaluated individually. Results: A total of 104 patients (median age, 57 years) were treated; characteristics were similar for both arms. Median follow-up for RT with capecitabine/irinotecan arm was 3.77 years and for RT with capecitabine/oxaliplatin arm was 3.97 years. Four-year DFS, OS, LRF, DF, and SP estimates for capecitabine/irinotecan arm were 68%, 85%, 16%, 24%, and 2%, respectively. The 4-year DFS, OS, LRF, DF, and SP failure estimates for capecitabine/oxaliplatin arm were 62%, 75%, 18%, 30%, and 6%, respectively. Conclusions: Efficacy results for both arms are similar to other reported studies but suggest that pathologic complete remission is an unsuitable surrogate for traditional survival metrics of clinical outcome. Although it remains uncertain whether the addition of a second cytotoxic agent enhances the effectiveness of fluorouracil plus RT, these results suggest that further study of irinotecan may be warranted.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Magnetisation studies of phase co-existence in Gd{sub 1-x}Ca{sub x}BaCo{sub 2}O{sub 5.5}

Highlights: Black-Right-Pointing-Pointer The series Gd{sub 1-x}Ca{sub x}BaCo{sub 2}O{sub 5.5} was synthesised by solid state reaction. Black-Right-Pointing-Pointer Magnetisation studies were carried out in the 4-300 K temperature range in magnetic fields upto 16 Tesla. Black-Right-Pointing-Pointer Results were used to formulate the T versus Ca fraction, phase diagram. Black-Right-Pointing-Pointer Evidence for Magnet-electronic phase separation is shown for the first time in the compound. -- Abstract: Magnetic properties of hole doped, oxygen deficient double perovskite compounds, Gd{sub 1-x}Ca{sub x}BaCo{sub 2}O{sub 5.5}, have been investigated. Ferromagnetic transition temperatures increase and the anti-ferromagnetic transition temperatures decrease with Ca substitution leading to stabilisation of ferromagnetisim for x {>=} 0.05. A detailed study of the ferromagnetic phase indicates the presence of double hysterisis loops for Ca fractions, 0.05 {<=} x {<=} 0.2 in the 50-200 K temperature range, suggestive of the co-existence of two ferromagnetic phases with different co-ercivities. Based on the magnetisation and transport measurements a phase diagram is proposed for Ca doped GdBaCo{sub 2}O{sub 5.5}.

36 MATERIALS SCIENCE↗

Prostate Hypofractionated Radiation Therapy With Injection of Hyaluronic Acid: Acute Toxicities in a Phase 2 Study

Purpose: Hypofractionated radiation therapy (RT) in prostate cancer can be developed only if the risk of rectal toxicity is controlled. In a multicenter phase 2 trial, hypofractionated irradiation was combined with an injection of hyaluronic acid (HA) to preserve the rectal wall. Tolerance of the injection and acute toxicity rates are reported. Methods and Materials: The study was designed to assess late grade 2 toxicity rates. The results described here correspond to the secondary objectives. Acute toxicity was defined as occurring during RT or within 3 months after RT and graded according to the Common Terminology Criteria for Adverse Events version 4.0. HA tolerance was evaluated with a visual analog scale during the injection and 30 minutes after injection and then by use of the Common Terminology Criteria at each visit. Results: From 2010 to 2012, 36 patients with low-risk to intermediate-risk prostate cancer were included. The HA injection induced a mean pain score of 4.6/10 ± 2.3. Thirty minutes after the injection, 2 patients still reported pain (2/10 and 3/10), which persisted after the intervention. Thirty-three patients experienced at least 1 acute genitourinary toxicity and 20 patients at least 1 acute gastrointestinal toxicity. Grade 2 toxicities were reported for 19 patients with urinary obstruction, frequency, or both and for 1 patient with proctitis. No grade 3 or 4 toxicities were reported. At the 3-month visit, 4 patients described grade 2 obstruction or frequency, and no patients had any grade 2 gastrointestinal toxicities. Conclusions: The injection of HA makes it possible to deliver hypofractionated irradiation over 4 weeks with a dose per fraction of > 3 Gy, with limited acute rectal toxicity.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy

Background: Two phase 2 trials of oxaliplatin-containing adjuvant therapy for patients with gastric cancer (GC) after D2 gastrectomy were conducted in Japan. The SOXaGC trial evaluated the tolerability and safety of adjuvant therapy with S-1 plus oxaliplatin (SOX), whereas the J-CLASSIC trial evaluated the feasibility of adjuvant therapy with capecitabine plus oxaliplatin (CAPOX). Because both were studies that did not evaluate survival results as study end points, the authors evaluated the survival outcomes for the patients in the two trials. Methods: All 62 and 100 patients in the full analysis set of the SOXaGC and J-CLASSIC trials, respectively, were included in the current study. Their information about survival outcome was collected. The primary end point was relapse-free survival (RFS), and the secondary end point was overall survival (OS). Results: For the pathologic stage (pStage 2) patients treated with CAPOX, the 3-year RFS rate was 87.8% and the 3-year OS rate was 92.7%. For the pStage 3 patients treated with SOX and CAPOX, the 3-year RFS rates were respectively 70.9% and 67.8% (hazard ratio [HR], 0.93; 95% confidence interval [CI], 0.50–1.72), whereas the 3-year OS rates were respectively 75.7% and 79.3% (HR, 1.10; 95% CI, 0.54–2.26). Subgroup analysis showed significant interactions between the treatment (SOX vs. CAPOX) and both sex (male vs. female; P = 0.024) and histologic type (diffuse vs. other, P = 0.069). Conclusions: This exploratory analysis demonstrated that SOX and CAPOX are suggested to have similar efficacy for pStage 3 GC patients after D2 gastrectomy. Differences in the treatment effect according to sex and histologic type warrant further evaluation.

62 RADIOLOGY AND NUCLEAR MEDICINE↗